Literature DB >> 1556146

Cell cycle-associated expression of M2-type isozyme of pyruvate kinase in proliferating rat thymocytes.

R Netzker1, E Greiner, E Eigenbrodt, T Noguchi, T Tanaka, K Brand.   

Abstract

During a complete cell cycle of rat thymocytes stimulated by concanavalin A and interleukin 2, the activity and mRNA level of pyruvate kinase reached a maximum (8-12-fold increase) 48 h after stimulation coinciding with the S-phase of the cell cycle. Increases of cellular enzyme activity, pyruvate kinase protein, and mRNA levels are correlated up to 48 h of culture. Afterwards pyruvate kinase activity and mRNA levels decrease, whereas the pyruvate kinase protein continues to increase throughout mitosis. This change of specific pyruvate kinase activity points to a posttranslational modification of the enzyme besides its transcriptional regulation. The presence of the M2-type isozyme was determined by the following methods: (a) native cellulose acetate electrophoresis and activity staining, (b) Northern blot hybridization with M1- and M2-specific cDNA probes, and (c) determination of kinetic parameters. The isozyme pattern did not change during the cell cycle progression. The induction of pyruvate kinase is completely abolished by 2-difluoromethylornithine-mediated polyamine depletion. However, the proportion of hybridizable pyruvate kinase mRNA was not affected. These data suggest the requirement of polyamines for efficient translation rather than transcription during cell growth.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1556146

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  In silico studies of energy metabolism of normal and diseased heart.

Authors:  S M Ngai; M M Way; H Chan; S K Tsui; C Y Lee; K P Fung
Journal:  Mol Biol Rep       Date:  2000-06       Impact factor: 2.316

Review 2.  Pyruvate kinase: Function, regulation and role in cancer.

Authors:  William J Israelsen; Matthew G Vander Heiden
Journal:  Semin Cell Dev Biol       Date:  2015-08-13       Impact factor: 7.727

3.  Power of screening tests for colorectal cancer enhanced by high levels of M2-PK in addition to FOBT.

Authors:  Cristina Zaccaro; Ilaria Maria Saracino; Giulia Fiorini; Natale Figura; John Holton; Valentina Castelli; Valeria Pesci; Luigi Gatta; Dino Vaira
Journal:  Intern Emerg Med       Date:  2017-02-02       Impact factor: 3.397

Review 4.  Brick by brick: metabolism and tumor cell growth.

Authors:  Ralph J Deberardinis; Nabil Sayed; Dara Ditsworth; Craig B Thompson
Journal:  Curr Opin Genet Dev       Date:  2008-04-02       Impact factor: 5.578

Review 5.  The role of phosphometabolites in cell proliferation, energy metabolism, and tumor therapy.

Authors:  S Mazurek; C B Boschek; E Eigenbrodt
Journal:  J Bioenerg Biomembr       Date:  1997-08       Impact factor: 2.945

Review 6.  Aerobic glycolysis by proliferating cells: protection against oxidative stress at the expense of energy yield.

Authors:  K Brand
Journal:  J Bioenerg Biomembr       Date:  1997-08       Impact factor: 2.945

Review 7.  Nutrient and hormonal regulation of pyruvate kinase gene expression.

Authors:  K Yamada; T Noguchi
Journal:  Biochem J       Date:  1999-01-01       Impact factor: 3.857

8.  Inhibition of immediate-early-gene induction in renal mesangial cells by depletion of intracellular polyamines.

Authors:  E Schulze-Lohoff; H Fees; S Zanner; K Brand; R B Sterzel
Journal:  Biochem J       Date:  1994-03-15       Impact factor: 3.857

9.  Proviral insertion in murine lymphomas 2 (PIM2) oncogene phosphorylates pyruvate kinase M2 (PKM2) and promotes glycolysis in cancer cells.

Authors:  Zhenhai Yu; Xiaoping Zhao; Liangqian Huang; Teng Zhang; Fajun Yang; Lei Xie; Shaoli Song; Ping Miao; Li Zhao; Xiaoguang Sun; Jianjun Liu; Gang Huang
Journal:  J Biol Chem       Date:  2013-10-18       Impact factor: 5.157

10.  Resveratrol inhibits cancer cell metabolism by down regulating pyruvate kinase M2 via inhibition of mammalian target of rapamycin.

Authors:  Mohd Askandar Iqbal; Rameshwar N K Bamezai
Journal:  PLoS One       Date:  2012-05-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.